Literature DB >> 12732935

Clustering of neuronal inclusions in "dementia with neurofilament inclusions".

N J Cairns1, R A Armstrong.   

Abstract

Dementia with neurofilament inclusions (DNI) is a new disorder characterized clinically by early-onset dementia and histologically by the presence of intraneural inclusions immunopositive for neurofilament antigens but lacking tau and alpha-synuclein reactivity. We studied the clustering patterns of the neurofilament inclusions (NI) in regions of the temporal lobe in three cases of DNI to determine whether they have the same spatial patterns as inclusions in the tauopathies and alpha-synucleinopathies. The NI exhibited a clustered distribution (mean size of clusters 400 microm, range 50-800 microm, SD 687.8) in 24/28 of the areas studied. In 22 of these areas, the clusters exhibited a regular distribution along the tissue parallel to the pia mater or alveus. In 3 cortical areas, there was evidence of a more complex pattern in which the NI clusters were aggregated into larger superclusters. In 6 cortical areas, the size of the clusters approximated to those of the cells of origin of the cortico-cortical pathways but in the remaining areas cluster size was smaller than 400 microm. Despite the unique molecular profile of the NI, their spatial patterns are similar to those shown by filamentous neuronal inclusions in the tauopathies and alpha-synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732935     DOI: 10.1007/s00401-003-0710-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

1.  alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Authors:  Nigel J Cairns; Kunihiro Uryu; Eileen H Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Steven E Arnold; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2004-05-28       Impact factor: 17.088

2.  PRKAR1B mutations are a rare cause of FUS negative neuronal intermediate filament inclusion disease.

Authors:  Cyril Pottier; Matt Baker; Dennis W Dickson; Rosa Rademakers
Journal:  Brain       Date:  2014-11-20       Impact factor: 13.501

3.  Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hideaki Yokoo; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2011-07-27       Impact factor: 3.575

4.  The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hedeaki Yokoo; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2010-10-01       Impact factor: 17.088

5.  Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.

Authors:  R A Armstrong; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2006-11-17       Impact factor: 3.575

6.  3' untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells.

Authors:  Hong Lin; Jinbin Zhai; Rafaela Cañete-Soler; William W Schlaepfer
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

7.  alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

Authors:  Nigel J Cairns; Victoria Zhukareva; Kunihiro Uryu; Bin Zhang; Eileen Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.